Information: Due to increasing bot activity we were unfortunately forced to place the search behind a login. Links to models can still be shared with others and viewed without a login. Thank you for your understanding.
Information:
Fel:
ID
21969
Beskrivning
A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone; ODM derived from: https://clinicaltrials.gov/show/NCT00240006
Länk
https://clinicaltrials.gov/show/NCT00240006
Nyckelord
Versioner (1)
- 2017-05-11 2017-05-11 -
Uppladdad den
11 maj 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Multiple Sclerosis NCT00240006
Eligibility Multiple Sclerosis NCT00240006
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT00240006
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
1. males or females, 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting | Recurrent disease
Item
2. diagnosed with relapsing remitting multiple sclerosis (relapses accepted).
boolean
C0751967 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C0277556 (UMLS CUI [2])
glatiramer acetate | Copaxone
Item
3. beginning or restarting therapy with glatiramer acetate (copaxone®).
boolean
C0289884 (UMLS CUI [1])
C0528175 (UMLS CUI [2])
C0528175 (UMLS CUI [2])
Protocol Compliance
Item
4. willing and able to complete all procedures and evaluations related to the study.
boolean
C0525058 (UMLS CUI [1])
Informed Consent
Item
5. willing to provide informed consent.
boolean
C0021430 (UMLS CUI [1])
Biological Response Modifiers | Therapeutic immunosuppression | Copaxone
Item
1. taking any other immunomodulatory or immunosuppressant therapy in conjunction with copaxone®.
boolean
C0005525 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
C0528175 (UMLS CUI [3])
C0021079 (UMLS CUI [2])
C0528175 (UMLS CUI [3])
Illness Interferes with Endpoints Assessment | Multiple Sclerosis | Illness Interferes with Study Subject Participation Status
Item
2. has a significant medical illness other than ms that may interfere with the assessment of endpoints or the subject's participation in the trial for the full duration of the study.
boolean
C0221423 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2349179 (UMLS CUI [1,3])
C1516048 (UMLS CUI [1,4])
C0026769 (UMLS CUI [2])
C0221423 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C2348568 (UMLS CUI [3,3])
C0521102 (UMLS CUI [1,2])
C2349179 (UMLS CUI [1,3])
C1516048 (UMLS CUI [1,4])
C0026769 (UMLS CUI [2])
C0221423 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C2348568 (UMLS CUI [3,3])
Condition Interferes with Study Subject Participation Status
Item
3. any situation that the investigator or nurse (if not the investigator) feel may interfere with participation in the study.
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
Pregnancy | Pregnancy, Planned | Breast Feeding
Item
4. pregnant or trying to become pregnant, or breast feeding during the study.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Study Subject Participation Status
Item
5. previously participated in this study or another clinical research study in the past 30 days.
boolean
C2348568 (UMLS CUI [1])